These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 27545871)

  • 1. Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy Subjects.
    Morcos PN; Parrott N; Banken L; Timpe C; Lindenberg M; Guerini E; Dall G; Bogman K; Sturm C; Zeaiter A; Martin-Facklam M; Phipps A
    Clin Pharmacol Drug Dev; 2017 May; 6(3):266-279. PubMed ID: 27545871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy Subjects.
    Morcos PN; Guerini E; Parrott N; Dall G; Blotner S; Bogman K; Sturm C; Balas B; Martin-Facklam M; Phipps A
    Clin Pharmacol Drug Dev; 2017 Jul; 6(4):388-397. PubMed ID: 27545320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability and food effect study of an oral suspension of alectinib in healthy volunteers using venipuncture and capillary microsampling.
    Liu SN; Agarwal P; Heinig K; Datye A; Sturm-Pellanda C; Crugnola A; Arca M; Miles D
    Clin Transl Sci; 2023 Jun; 16(6):1085-1096. PubMed ID: 36978270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib.
    Morcos PN; Cleary Y; Guerini E; Dall G; Bogman K; De Petris L; Viteri S; Bordogna W; Yu L; Martin-Facklam M; Phipps A
    Clin Pharmacol Drug Dev; 2017 May; 6(3):280-291. PubMed ID: 27545757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioequivalence of two lansoprazole delayed release capsules 30 mg in healthy male volunteers under fasting, fed and fasting-applesauce conditions: a partial replicate crossover study design to estimate the pharmacokinetics of highly variable drugs.
    Thota S; Khan SM; Tippabhotla SK; Battula R; Gadiko C; Vobalaboina V
    Drug Res (Stuttg); 2013 Nov; 63(11):551-7. PubMed ID: 23780504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effects of formulation and food on the pharmacokinetics of lenvatinib (E7080) in healthy volunteers.
    Shumaker R; Aluri J; Fan J; Martinez G; Ren M; Chen K
    Int J Clin Pharmacol Ther; 2014 Apr; 52(4):284-91. PubMed ID: 24548978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence and pharmacokinetic evaluation of two tablet formulations of carvedilol 25-mg: a single-dose, randomized-sequence, open-label, two-way crossover study in healthy Chinese male volunteers.
    Liu Y; Lu C; Chen Q; Wang W; Liu GY; Lu XP; Zhang MQ; Yu C; Jia JY
    Drug Res (Stuttg); 2013 Feb; 63(2):74-8. PubMed ID: 23447077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saquinavir 500 mg film-coated tablets demonstrate bioequivalence to saquinavir 200 mg hard capsules when boosted with twice-daily ritonavir in healthy volunteers.
    Bittner B; Riek M; Holmes B; Grange S
    Antivir Ther; 2005; 10(7):803-10. PubMed ID: 16312177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption, distribution, metabolism and excretion (ADME) of the ALK inhibitor alectinib: results from an absolute bioavailability and mass balance study in healthy subjects.
    Morcos PN; Yu L; Bogman K; Sato M; Katsuki H; Kawashima K; Moore DJ; Whayman M; Nieforth K; Heinig K; Guerini E; Muri D; Martin-Facklam M; Phipps A
    Xenobiotica; 2017 Mar; 47(3):217-229. PubMed ID: 27180975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioequivalence of fixed dose combination of atorvastatin 10 mg and aspirin 150 mg capsules: a randomized, open-label, single-dose, two-way crossover study in healthy human subjects.
    Tippabhotla SK; Betha MR; Gadiko C; Battula R; Nakkawar M; Cheerla R; Khan SM; Yergude S; Thota S; Vobalaboina V
    Drug Res (Stuttg); 2013 May; 63(5):250-7. PubMed ID: 23526241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: a randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers.
    Parrillo-Campiglia S; Ercoli MC; Umpierrez O; Rodríguez P; Márquez S; Guarneri C; Estevez-Parrillo FT; Laurenz M; Estevez-Carrizo FE
    Clin Ther; 2009 Oct; 31(10):2224-32. PubMed ID: 19922893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Hepatic Impairment on the Pharmacokinetics of Alectinib.
    Morcos PN; Cleary Y; Sturm-Pellanda C; Guerini E; Abt M; Donzelli M; Vazvaei F; Balas B; Parrott N; Yu L
    J Clin Pharmacol; 2018 Dec; 58(12):1618-1628. PubMed ID: 30052269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Open-Label, Randomized, 2-Way, Crossover Bioequivalence Study of Cefradine Capsules in Healthy Chinese Volunteers.
    Lai X; Ye S; Chen L; Chen J; Zhang N; Zhang Y; Wu J; Yao H
    Clin Pharmacol Drug Dev; 2021 Dec; 10(12):1478-1484. PubMed ID: 34148297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and bioequivalence of low-dose clopidogrel in healthy Chinese volunteers under fasted and fed conditions.
    Gong L; Fu C; Bi L; Kuang Y; Guo C; Wei G; Yan Z; Huang J; Yang G
    Drug Metab Pharmacokinet; 2019 Oct; 34(5):300-307. PubMed ID: 31239099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative bioavailability and fasting pharmacokinetics of three formulations of olmesartan medoxomil 20-mg capsules and tablets in healthy Chinese male volunteers: An open-label, randomized-sequence, single-dose, three-way crossover study.
    Li KY; Liang JP; Hu BQ; Qiu Y; Luo CH; Jiang Y; Lin XP; Yang N
    Clin Ther; 2010 Aug; 32(9):1674-80. PubMed ID: 20974325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioequivalence of single and multiple doses of venlafaxine extended-release tablets and capsules in the fasted and fed states: four open-label, randomized crossover trials in healthy volunteers.
    Wright CW; Aikman MS; Werts E; Seabolt J; Haeusler JM
    Clin Ther; 2009 Nov; 31(11):2722-34. PubMed ID: 20110014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metronidazole immediate release formulations: a fasting randomized open-label crossover bioequivalence study in healthy volunteers.
    de Freitas Silva M; Schramm SG; Kano EK; Koono EE; Manfio JL; Porta V; dos Reis Serra CH
    Arzneimittelforschung; 2012 Oct; 62(10):490-5. PubMed ID: 22918856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferation.
    Petrides PE; Gisslinger H; Steurer M; Linkesch W; Krumpl G; Schüller A; Widmann R
    Clin Ther; 2009 Feb; 31(2):386-98. PubMed ID: 19302911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.